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injury rates for secondary operations than for primary
CEA. A recent pooled (meta) analysis of 511 secondary
CEAs indicated a 3.9% perioperative stroke rate and a 1%
perioperative mortality rate.19 Other recent series also
conclude that secondary carotid artery procedures have
similar perioperative mortality and stroke rates as do pri-
mary CEAs performed by the same surgeons.6,12,17 The
pathologic plaque findings are predominantly neointimal
hyperplasia in the first 2 to 3 years after primary CEA, and
most are atherosclerotic thereafter; however, both throm-
bus and dense scarring have also been reported. The site
of recurrent stenosis is primarily at the ends of or within
the endarterectomized segment, either in the internal
carotid artery or the distal common carotid artery or
both.
Two frequently raised and controversial questions
regarding patients requiring recurrent carotid artery oper-
ations are, first, the role of primary CEA reconstruction
on the incidence of reoperation and, second, the out-
comes of two types of secondary operations, patch recon-
Operative procedures for symptomatic and asympto-
matic recurrent carotid artery stenosis after carotid
endarterectomy (CEA) are infrequent. To date there are
only two reports of more than 100 procedures,1,2 10
reports of 50 to 99 procedures,3-12 and six reports of 25 to
49 procedures.13-18 Several of these are initial and follow-
up studies from the same institution. Earlier studies
reported higher perioperative mortality, stroke, and nerve
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Reoperations for carotid artery stenosis: Role of
primary and secondary reconstructions
Joseph P. Archie, Jr, PhD, MD, Raleigh, NC
Purpose: This is an analysis of the role of primary and secondary carotid artery reconstructions and systemic risk fac-
tors on the incidence and timing of reoperations and their perioperative and late outcomes.
Methods: This is a retrospective analysis of prospectively stored data. Between 1981 and 1999, 69 secondary carotid
artery procedures were performed on 66 patients (3 were bilateral). Of these, 29 operations and patients came from
my series of 1514 primary carotid endarterectomies (CEAs). Overall, secondary operations were performed on 37
women (1 bilateral) and 29 men (2 bilateral) with a mean age of 68 years. Indications for reoperation were transient
ischemic attack in 27%, stroke in 12%, global ischemia in 9%, and asymptomatic ≥ 70% recurrent stenosis in 52%.
Secondary reconstruction was by saphenous vein patching in 57% (n = 39), Dacron patching in 29% (n = 20), poly-
tetrafluoroethylene patch in 1% (n = 1), and interposition bypass graft in 13% (n = 9). The main outcome measures
included restenosis, re-restenosis, and perioperative and late stroke and death.
Results: Reoperations were more frequent after originally primarily closed CEA (6.2%) than after patched CEA (1.6%,
P = .01). Reoperations after Dacron-patched CEA occurred at a mean of 16 months compared with a mean of 84
months for vein-patched CEA (P < .001). Male sex and history of smoking have a slightly adverse but not statistically
significant effect on the incidence and time of reoperation. Restenosis in the distal common carotid artery requiring
reoperation had a near-linear rate of occurrence, whereas that in the internal carotid artery segment was bimodal with
a higher incidence in the first 3 years and after 7 years. There were no (0%) 30-day perioperative deaths. There were
two (2.9%) 30-day strokes (1 major, 1 minor). Over a mean follow-up of 50 months (range, 1-180), the Kaplan-Meier
cumulative survival was 74% at 5 years and 54% at 10 years. This is significantly higher than late death after primary
CEA independent of age. The cumulative freedom from stroke rate was 90% at 5 years and 86% at 10 years. After sec-
ondary procedures re-recurrent stenosis ≥ 25% occurred in 25% (n = 17), ≥ 50% in 13% (n = 9), and ≥ 70% in 4% (n =
3). There was no statistically significant difference in stroke or re-restenosis rates between vein-patched, Dacron-
patched, and bypassed reoperations, although re-recurrence tended to occur earlier after Dacron-patched than vein-
patched procedures. Analysis of pooled literature data and the results of this study for stroke and re-restenosis outcomes
by type secondary reconstruction (patch versus bypass graft) and by material (vein versus synthetic) give a balanced pic-
ture of near equality for each. Vein- and Dacron-patched arteries have similar outcomes, whereas polytetrafluoroethyl-
ene appears to be superior to vein and Dacron for interposition bypass graft.
Conclusions: Secondary carotid artery operations are more frequent after primarily closed CEA than patched CEA.
Perioperative mortality and stroke rates for reoperations are within the acceptable window of primary CEA. The inci-
dence of late death after reoperations is higher than after primary CEA. The perioperative stroke, late stroke, and re-
restenosis outcomes of vein- and Dacron-patched secondary operations are similar, as are those for patched and
bypassed carotid arteries. (J Vasc Surg 2001;33:495-503.)
struction with or without endarterectomy, and inter-
position bypass graft. Although there is a great deal of
published information on the role of primary CEA recon-
struction on restenosis, there are few data on the effect of
primary reconstruction on the incidence of reoperations.
Recently, Meyer et al7 reported that 13 (3.1%) of 426 pri-
marily closed CEAs and 44 (1.6%) of 2685 (P = .043)
patched CEAs underwent secondary carotid artery opera-
tive procedures. Similarly there is little information on the
role of secondary CEA reconstruction methods on peri-
operative and late outcomes. Rockman et al10 recently
reported that interposition bypass grafting has a slightly
higher perioperative neurologic complication rate but is
more durable than secondary endarterectomy and patch
angioplasty. They also found that prosthetic materials
(bypass and patch) have a lower re-restenosis or occlusion
rate than does autologous saphenous vein.10 Treiman et
al2 found interposition bypass grafting with saphenous
vein to be as safe and durable as re-endarterectomy and
Dacron patch closure. This is an analysis of the role of pri-
mary CEA reconstruction on restenosis necessitating sec-
ondary CEA and that of re-reconstructions on secondary
CEA perioperative and late outcomes.
METHODS
Patient demographics, indications, systemic risk
factors, and preoperative evaluation. From August
1981 to June 1999, 69 reoperative carotid artery proce-
dures were performed on 66 patients (bilateral in 2 men
and 1 woman). Of these, 29 patients and operations came
from a pool of 1514 primary CEAs that I performed
(1.9%). The other 40 secondary operations were on 37
patients who had undergone primary CEA by other sur-
geons. Secondary operations constituted 4.4% (69/1583)
of the CEAs that I performed during this 18-year period.
One patient had bilateral severe recurrent stenosis and
global ischemic symptoms and underwent staged proce-
dures 1 month apart. The other two patients who under-
went bilateral procedures had development of high-grade
contralateral restenosis 2 and 5 years after the initial sec-
ondary operation. There were 31 reoperations on 29 men
and 38 reoperations on 37 women. The ages were 67.8 ±
8.5 (mean ± 1 SD) years. In the analysis of the role of pri-
mary CEA reconstruction on reoperation only, the results
of my 29 original CEAs are given because they had close
follow-up. Complete information regarding the primary
procedure and follow-up of patients operated on by other
surgeons was rare.
Indications were transient ischemia in 19 (27.5%),
including six with amaurosis fugax, completed nondebili-
tating stroke in eight (11.6%), global symptoms in six
(8.7%), and asymptomatic ≥ 70% diameter stenosis in 36
(52.2%) patients. Of the 29 patients on whom I per-
formed the original CEA, only seven (24.1%) had symp-
toms as compared with 26 (65%) symptomatic sides in the
referred group (P = .066). My patients in whom resteno-
sis ≥ 50% developed in the first 2 years after primary CEA
were followed up at 3 to 6 months with duplex scanning.
Only those in whom stenosis progressed to ≥ 70% diame-
ter or who had development of symptoms underwent
reoperation. Although there are no prospective studies
that predict at which level of recurrent stenosis symptom-
free patients are advised to undergo a reoperation, I have
used ≥ 70% diameter stenosis as the criterion. Systemic risk
factors at the time of reoperation included current and
continued cigarette smoking in 56 (84.8%), hypertension
in 49 (74.2%), coronary artery disease in 53 (80.3%), and
diabetes mellitus in 11 (16.7%). Serum lipid levels were
obtained on less than half of the patients at the time of
reoperation, and therefore, this risk factor is not included.
Standard arterial digital arteriography was performed
before 61 (88%) procedures. Duplex scanning alone or
combined with magnetic resonance angiography was suf-
ficient in eight (12%). All eight occurred late in this series
as I moved away from obligatory angiography. The reop-
erated carotid artery diameter stenosis was 83.8% ± 8.1%
(mean ± 1 SD). The North American Symptomatic
Carotid Endarterectomy Trial method was used to deter-
mine percent stenosis. The contralateral internal carotid
artery was occluded in seven patients (11%). Two patients
underwent secondary carotid artery procedures concomi-
tant with coronary artery bypass graft. The location of
restenosis and re-restenosis was classified as being in either
the internal carotid artery or the common carotid artery,
although six arteries had both. For these six the location
of the highest grade stenosis is given in the results. There
were 31 right and 38 left secondary CEAs.
Operative management. General anesthesia was used
for all procedures. Standard surgical technique included
careful dissection with minimal exposure of the previously
endarterectomized segment, optical magnification, sys-
temic administration of heparin, and selective shunting on
the basis of stump-back pressure (seven shunts used). The
decision for endarterectomy with patch angioplasty, patch
angioplasty alone, or interposition bypass grafting was not
randomized but rather was based on operative findings.
Of the nine (13%) patients undergoing bypass grafting,
three had severe restenosis early after primary CEA, and
bypass grafting was mandated because the internal carotid
bulb segment was densely scarred and externally narrowed
such that endarterectomy could not be performed, and
patching alone would not give an anatomically or hemo-
dynamically adequate result. The other six patients had a
bypass graft placed because of the extent of the recurrent
disease or an extremely ragged or damaged surface after
repeat endarterectomy. An autologous greater saphenous
vein bypass graft was used in eight cases, and a polytetra-
fluoroethylene (PTFE) bypass graft was used in one
patient who did not have an adequate vein. Patch angio-
plasty was used in the other 60 (87%) patients, of whom
51 (73.9%) also underwent endarterectomy. An autolo-
gous greater saphenous vein patch was placed in 39
(56.5%) patients, a knitted Dacron patch in 20 (29.0%),
and a PTFE patch in one (1.4%). Synthetic patches were
used when saphenous vein was not available or was inade-
quate and during 1994 to 1997 when I selectively used a
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collagen-impregnated knitted Dacron patch. On the basis
of intraoperative bidirectional continuous-wave Doppler
ultrasound interrogation, no procedure required revision.
A drain was placed after all secondary operations.
After operation all patients were monitored overnight
with electrocardiography and systemic (radial) arterial
pressure. The mean postoperative hospital stay was 3.3
days for the entire series and 1.8 days for the last 20
patients. All patients were given aspirin, dipyridamole, or
both.
Follow-up. Patients were seen in the office approxi-
mately 1 week after surgery. Duplex scanning was advised
and scheduled for 2 and 6 months and annually (Mark 8 and
later Ultra Mark 9; Advanced Technology Laboratory,
Bothell, Wash). Criteria for residual or recurrent stenosis
were 25% to 49% stenosis, a peak systolic velocity of 125
cm/s or more, 50% to 69% stenosis, a peak systolic velocity
of 160 cm/s or more with spectral broadening in systole and
≥ 70%, a stenosis peak systolic velocity of 270 cm/s or more,
and an end-diastolic velocity of 100 cm/s or more.
Statistical analysis. The 95% CI for proportions was
computed from the normal distribution when the numer-
ator was 5 or more and from the binomial distribution
when it was less than 5. Differences in proportions were
tested with the 2-tailed Fisher exact test when one
expected numerator was less than 5 and otherwise by χ2
analysis. The probability of death, stroke, and recurrent
and re-recurrent stenosis with and without specific sys-
temic or local risk factors was analyzed with the Kaplan-
Meier method with P values computed with log-rank
(long-term) and Wilcoxon (short-term) methods. Kaplan-
Meier rates are given as percent ± 1 SE. A special feature
of Kaplan-Meier analysis when all subjects reach an event
in time (no censored subjects) was used in Figs 1, 2 and 3
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to illustrate the time course of reoperation after primary
CEA. The number at risk at each time is obvious, and the
standard errors balloon out at midtime and converge to
zero at the finish and accordingly are not given for these
three figures. Cox proportional hazard analysis was used
to test the relative risk of restenosis and re-restenosis for
sex, age, and smoking. Cox analyses were run simultane-
ously and individually. Continuous variables were analyzed
with unpaired t tests. Summary statistics are given as mean
± 1 SD and proportions as fraction, percent, and ± 95%
CI. All data were stored prospectively in a computer reg-
istry. Calculations were performed with Stat View 5.01
(SAS Institute, Cary, NC).
Fig 1. Kaplan-Meier analysis of time from primary CEA to reop-
eration for vein-patched (n = 15), Dacron-patched (n = 6), and
primarily closed (n = 6) carotid arteries (P < .001 for vein vs
Dacron and vein versus primary closure).
Fig 2. Kaplan-Meier analysis of time from primary CEA to reop-
eration for smokers (n = 20) and nonsmokers (n = 9) (P = .47).
Fig 3. Kaplan-Meier analysis of time from primary CEA to reop-
eration by location of major restenosis in internal (n = 17) or dis-
tal common carotid artery (n = 12) (P = .65).
RESULTS
Role of primary CEA reconstruction, sex, and
smoking on the time and location of restenosis for the
29 patients with known follow-up. The incidence of the
29 secondary operations from my pool of 1514 consecu-
tive primary CEAs by type of primary reconstruction for
sex, smoking, and location of restenosis is given in Table
I. All six of the secondary operations in initially primarily
closed CEA came from the subset of 96 obligatorily pri-
marily closed CEAs (6.2%) that were performed in 1981
to 1983, before initiation of a protocol of obligatory patch
angioplasty reconstruction if the arteriotomy required to
obtain a complete internal carotid endarterectomy end
point extended beyond the bulb segment. After this pro-
tocol was invoked, the 0% incidence (95% CI, 0%-6.8%) of
reoperation for 51 primary closed CEAs was lower but not
statistically lower than the earlier experience of 6% (P =
.093). The incidence of reoperation on arteries that origi-
nally underwent saphenous vein patch reconstruction was
significantly lower than for all primary closed versus vein-
patched CEAs (P = .043) and for primary closures during
1981 to 1983 (P = .012). Most Dacron patches were used
between 1994 and 1997, with shorter follow-up than
vein-patched and primary closed CEAs. Fig 1 is a Kaplan-
Meier analysis showing that primary CEA reconstruction
with vein patches has a statistically significantly later devel-
opment of restenosis requiring reoperations than do
Dacron-patched and primary closed CEAs. The mean
time from my primary CEA to reoperation was 16.5
months for primary closure, 22.8 months for Dacron
patching, and 83.7 months for vein patching.
As given in Table I, secondary reoperations on my
original CEAs were statistically significantly more frequent
in women than in men. Men tended to be younger (64.8
± 9.7 years) than women (70.8 ± 8.2 years, P = .003) at
the time of reoperation. The mean time from my 29 pri-
mary CEAs to reoperation was almost identical in men
and women (58.4 vs 56.0 months). Although the inci-
dence of reoperation was similar in smokers and non-
smokers, smokers were slightly younger (64.8 ± 9.7 years
vs 74.1 ± 5.5 years, P = .012) at the time of reoperation.
Men were more likely to continue smoking (8/8) than
women (12/21). Fig 2 is a Kaplan-Meier analysis showing
that smokers tended to undergo reoperation slightly but
not significantly earlier than nonsmokers (mean, 52 vs 63
months).
Cox analysis by the time of the 29 reoperations after
1514 primary CEAs gives risk ratios for reoperation of
2.38 (1.59-3.55 95% CI, P = .0001) for synthetic patch
versus vein patch, 1.56 (0.99-2.56, P = .054) for women
versus men, and 1.03 (0.51-1.95, P = .88) for smokers
versus nonsmokers. Cox analysis for each of the three vari-
ables taken individually gives 2.1 (1.51-2.97, P = .0001)
for synthetic patches, 1.37 (1.00-2.03, P = .033) for
women, and 0.97 (0.54-1.80, P = .85) for history of
smoking.
Fig 3 illustrates the tendency for internal carotid artery
recurrent stenosis to cluster in the first 3 years after pri-
mary CEA and again after 7 years, whereas common
carotid artery restenosis appears to have a near-linear rate
of occurrence. Restenosis occurred slightly later in the
common carotid artery than in the internal carotid artery
(mean, 68 vs 50 months). Smokers had development of
restenosis in the common carotid artery (10/20 [50%])
more frequently than nonsmokers (2/9 [22%], P = .012).
However, as shown in Fig 2, smokers also had develop-
ment of restenosis earlier than nonsmokers. This paradox
may be explained by the higher incidence of Dacron-
patched CEA in nonsmokers. The sex-related difference in
location of restenosis was significant. Common carotid
artery restenosis was more frequent in men (6/8 [75%])
than in women (6/21 [28.6%], P = .04). Common carotid
artery restenosis was more frequent in vein-patched CEA
(60.0%) than in the other types and materials used in pri-
mary CEA: primarily closed CEA (33.3%), Dacron-
patched CEA (0%), PTFE-patched CEA (0%), and
interposition bypass grafts (10.0%) (P = .017 by χ2). The
sex-related difference for type of primary CEA reconstruc-
tion was not statistically different.
Relationship of age, sex, smoking, and location of
JOURNAL OF VASCULAR SURGERY
498 Archie March 2001
Table I. Incidence of 29 secondary operations from 1514 primary CEAs by type of reconstruction, sex, smoking, and
the location of recurrent stenosis
Sex Smoking Location
Primary reconstruction type All Men Women Yes No ICA CCA
Primary closure 1981-1983 6/96 2/53 4/43 4/71 2/25 4 2
Primary closure 1984-1999 0/51 0/28 0/23 0/38 0/13 0 0
Saphenous vein patch 15/936 3/524 12/412 11/730 4/206 6 9
Dacron patch 6/383 2/209 4/174 4/312 2/71 6 0
PTFE patch 1/27 0/16 1/11 0/22 1/5 1 0
Interposition bypass graft 1/21 1/12 0/9 1/15 0/6 0 1
Total 29/1514 8/824 21/672 20/1188 9/326 17 12
Percent 1.9% 1.0% 3.1% 1.7% 2.8%
P value .004 .32
ICA, Internal carotid artery; CCA, common carotid artery.
restenosis for all secondary procedures. The average
was 67.8 ± 8.5 years. Men were slightly younger than
women, 66.0 ± 8.9 years versus 69.1 ± 7.8 years. Of the
29 men, 28 smoked (97%), whereas only 28 (76%) of the
37 women smoked (P = .034). Of the 45 originally pri-
marily closed CEAs, 25 were in men and 20 were in
women. Four of the 15 originally vein-patched CEAs were
in men, and 11 were in women. One Dacron-patched sec-
ondary CEA was in a man, and six were in women. The
single PTFE-patched CEA was in a woman, and the single
PTFE bypass graft was in a man. Of the 50 internal carotid
artery restenoses, 22 (44%) were in men, and 28 were in
women. Of the 19 common carotid artery restenoses, nine
were in men (47%), and 10 were in women. By logistic
regression there was no statistically significant relationship
between the location of restenosis or between type of pri-
mary reconstruction and the patients’ age, sex, or smok-
ing history. The 56 smokers were significantly younger
(66.1 ± 8.2 years) than the 10 nonsmokers (74.4 ± 5.3
years, P = .001) at the time of reoperation. The time from
the 69 primary CEAs to reoperation was 75.1 ± 56.7
months. By Kaplan-Meier analysis there were no signifi-
cant differences in time between primary CEA and reop-
eration for sex, history of smoking, or location of
restenosis. Table II summarizes the distribution of sex,
history of smoking, location of restenosis, as well as out-
comes by type of secondary reconstruction.
Perioperative outcomes for all secondary opera-
tions. There were no 30-day perioperative deaths and two
strokes (2.9%), one major and one minor. The major
stroke was due to acute internal carotid artery thrombosis
18 hours after an endarterectomy and vein patch recon-
struction. At operation the endarterectomized deep media
had a shaggy red hue appearance that was of concern. At
reexploration the internal carotid artery was thrombosed
without an identifiable technical defect. An interposition
graft was placed with restoration of normal flow; however,
the patient’s condition did not improve. This occurred
early in my experience with secondary operations, and
later I would have used an interposition bypass graft rather
than a patch. The minor stroke occurred in a patient with
preoperative changing neurologic events (unstable) that
may have been a stroke in evolution. The patient under-
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went interposition bypass grafting with PTFE. The neuro-
logic deficit cleared in 2 months. One patient who was
admitted with preoperative transient ischemic attacks had
several identical events after operation, presumably from
the same local focus of embolic induced ischemia. There
were three cranial nerve injuries (4.3%). All occurred early
in this series. One was an observed iatrogenic asympto-
matic partial division of the vagus nerve, one was a recur-
rent laryngeal nerve injury that resolved, and one was a
hypoglossal nerve injury that improved. There were no
myocardial infarctions or significant arrhythmias.
Survival and stroke late outcomes. The 10-year
Kaplan-Meier survival curve for the 66 patients is given in
Fig 4. The mean follow-up was 50 months. The 5-year
survival rate was 73.5%, and the 10-year rate was 53.5%.
The cause of the 17 deaths over the 15-year follow-up
were heart related in nine patients, neoplasm in three, kid-
ney failure in one, and unknown in four. Women had a
slightly but not significantly better 5-year (83.9%) and 10-
year (55.9%) survival rate than men (61.7% and 46.3%).
Nonsmokers also tended to have a longer 5-year survival
rate than smokers (90.0% vs 69.9%), but the survival rate
was equal at 10 years (54.0% vs 52.6%, P = .53).
Combined Cox proportional hazard analysis for death
gives a risk ratio for men of 2.4 with a 95% CI of 0.8 to
7.3 (P = .12), for smoking a risk ratio of 1.50 (0.35-6.4,
P = .58), and for age a risk ratio of 1.10 (1.02-1.18, P =
.016). Taken individually Cox analysis gives 1.9 (0.72-
4.75, P = .19) for men, 1.5 (0.43-5.2, P = .53) for smok-
ing, and 1.07 (1.0-1.4, P = .061) for age.
There were four late strokes in addition to the two 30-
day perioperative strokes. The Kaplan-Meier analysis of
freedom from all strokes for the 66 patients is given in Fig
4. The 5-year stroke-free rate was 90.3%, and the 10-year
rate was 86.0%. Of the four late strokes two were ipsilat-
eral to the secondary CEA, one was contralateral, and the
fourth was unknown. One patient with a late ipsilateral
stroke at 62 months had moderate re-recurrent stenosis of
a Dacron-patched CEA identified 7 months earlier. The
other patient with a late ipsilateral stroke had not under-
gone duplex scanning in 3 years, with the result of the last
one being normal. This patient underwent interposition
bypass grafting at the time of reoperation. All six strokes
Table II. Sex, smoking, location of restenosis, and outcomes by type of re-reconstruction for 69 procedures in 66
patients
N Sex Smoking Location Death Stroke Re-restenosis
Secondary
reconstruction Men Women Yes No ICA CCA ≥ 25% ≥ 50% ≥ 70%
Vein patch 39 16 23 32 7 29 10 11 2 12 5 3
Dacron patch 20 9 11 16 4 13 7 3 2 5 4 0
PTFE patch 1 0 1 1 0 1 0 0 0 0 0 0
Bypass graft 9 6 3 7 2 7 2 4 2 0 0 0
Total 69 31 38 56 13 50 19 18 6 17 9 3
ICA, Internal carotid artery; CCA, common carotid artery.
occurred in the 29 men versus none in the 37 women 
(P = .005). All six strokes occurred in patients who con-
tinued to smoke. Of the four patients with patch recon-
struction who had strokes, three also underwent
endarterectomy.
Re-recurrent stenosis. There were 17 ≥ 25% re-
restenosis, nine of which were ≥ 50%, and three of these
were ≥ 70%. None of the three patients with bilateral sec-
ondary procedures had a bilateral ≥ 25% re-restenosis, and
one had a unilateral re-recurrence. The Kaplan-Meier
analysis for ≥ 25% re-restenosis is given in Fig 5. The
cumulative 5-year rate was 23.9%, and the 10-year rate was
37.4%. Men had a slightly but not significantly higher ≥
25% re-restenosis rate than women at 5 years (31.1% vs
19.2%) and at 10 years (50.8% vs 27.3%, P = .093). There
was no difference in the ≥ 25% re-restenosis rate for smok-
ers and nonsmokers. Of the 50 patients with internal
carotid artery restenosis undergoing reoperation, 15
(30.0%) had development of ≥ 25% re-recurrence, and two
of the 19 common carotid artery restenoses recurred
(10.5%). Of the 38 patients undergoing vein-patched sec-
ondary CEA, 12 (31.6%) had development of mild or
greater re-restenosis, as did five (25%) of the 20 patients
undergoing Dacron-patched reoperations. However, all
five Dacron-patched re-restenoses occurred within 3 years,
whereas only five (41.7%) of the 12 vein-patched re-
restenoses did (P = .044). Nine of the 17 ≥ 25% re-recur-
rent stenoses were in the common carotid artery, and
eight were in the internal carotid artery. Seven (89.5%) of
the eight internal carotid artery re-recurrent stenoses
occurred within 5 years, as did four (44.4%) of the nine
common carotid artery re-recurrent stenoses. All eight of
the internal carotid artery re-recurrent stenoses had origi-
nal recurrent stenosis in the internal carotid artery,
whereas seven of the nine common carotid artery re-recur-
rences had original recurrent stenosis in the internal
carotid artery and two in the common carotid artery.
Endarterectomy did not play a role in re-recurrent steno-
sis because this occurred in 14 (27%) of the 51 arteries
with endarterectomy and patching and in three (33%) of
the nine with patching alone. Combined Cox propor-
tional hazard analysis for ≥ 25% re-restenosis gives the fol-
lowing risk ratios: for men 2.4 with a 95% CI of 0.81 to
7.2 (P = .11), for smoking 1.09 (0.26-4.6, P = .86), and
for age 1.03 (0.96-1.10, P = .47). Individual Cox analysis
gives 2.4 (0.84-6.8, P = .10) for men, 1.24 (0.35-4.4, P =
.74) for smoking, and 1.02 (0.95-1.09, P = .57) for age.
The Kaplan-Meier analysis of ≥ 50% re-restenosis is
given in Fig 5. The 5-year restenosis-free rate was 88.2%,
and the 10-year rate was 68.1%. There were four recur-
rences in carotid arteries in men (12.9%) and five in
women (13.2%). Of the 50 carotid arteries with primary
recurrence in the internal carotid artery, seven (14%) re-
recurred, five in the internal carotid artery and two in the
common carotid artery. Of the 18 carotid arteries with pri-
mary recurrence in the distal common carotid artery, two
(11%) re-recurred, both in the common carotid artery.
Seven (12.5%) of the 56 smokers had a ≥ 50% re-recurrence,
as did two (20%) of the 10 nonsmokers. Five (13.6%) of
the 38 vein-patched and four (20.0%) of the 20 Dacron-
patched reoperations had ≥ 50% re-recurrence. However,
by Kaplan-Meier analysis the 3-year re-restenosis rate was
33.2% for Dacron patching and 4.0% for vein patching 
(P = .021). Combined Cox proportional hazard analysis
gives a relative risk for ≥ 50% re-recurrence for men 
of 1.87 (0.42-8.3, P = .41), for smoking 1.37 (0.11-4.8,
P = .75), and for age 1.01 (0.91-1.1, P = .86). Individual
Cox analysis gives 1.7 (0.42-6.9, P = .46) for men, 0.87
(0.17-4.4, P = .86) for smoking, and 1.01 (0.92-1.12, 
P = .81) for age.
Three re-restenoses progressed to ≥ 70%, and all
underwent tertiary operations, two with interposition
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Fig 4. Kaplan-Meier analysis of survival and stroke rates after sec-
ondary carotid artery operations. SE is 6.7% at 5 years and 9.3%
at 10 years for survival. SE is 4.3% at 5 years and 5.9% at 10 years
for stroke.
Fig 5. Kaplan-Meier analysis for ≥ 25% and ≥ 50% re-restenosis
after secondary carotid artery operations. For ≥ 25% re-restenosis
SE is 6.7% at 5 years and 9.0% at 10 years. For ≥ 50% re-resteno-
sis SE is 5.1% at 5 years, 9.5% at 8 years, and at 13.3% 10 years.
bypass grafting and one with Dacron patching. The ter-
tiary reoperations were done at 25, 108, and 157 months.
All three had vein patch reconstruction at the secondary
operation. Two were in women and one in a man. Two
patients continued to smoke. Two tertiary recurrences
were in the common carotid artery, one of which had the
secondary recurrence there. The other common carotid
artery tertiary recurrence occurred in a patient who also
had a secondary endarterectomy in addition to patching.
The other tertiary ≥ 70% recurrence occurred early and
was in the internal carotid artery, as were the initial and
secondary recurrences.
DISCUSSION
For patients on whom I performed the primary CEA,
the type of reconstruction, primary closure or patch
angioplasty, and the patch material used, saphenous vein
or Dacron, were major determinants of the probability
and timing of secondary operations. Frequent use of pri-
mary closure resulted in a significantly higher incidence of
reoperations than did patch angioplasty. This observation
is not unexpected given the higher incidence of restenosis
after primary closure compared with patching.20,21 How-
ever, after initiation of a protocol of patching when the
arteriotomy required to obtain a complete end point
extended beyond the bulb segment, the incidence of
restenosis after primary closure decreased significantly.22
The time from primary CEA to reoperation was much
shorter for both primary closure and Dacron-patched
CEAs than for saphenous vein–patched CEA. In the first
3 years after primary operation, Dacron-patched CEA had
a significantly higher rate of reoperation than did vein-
patched CEA. This finding is not surprising because in my
series of primary CEAs, ≥ 50% restenosis occurred both
more frequently and earlier after Dacron-patched than
after vein-patched CEA.22,23
The 30-day perioperative stroke and mortality rates
for this series of 2.9% stroke (1 major and 1 minor) and no
deaths are consistent with my results for primary CEA and
with other recent publications.4,6,7,10-12 The 2.9% (2/69)
30-day perioperative stroke rate is higher than the 1.3%
(20/1514) rate for primary CEA that I performed during
the same time period. The combined 30-day mortality or
stroke rate of 2.9% (2/69) is similar to the 2.1%
(35/1514) for my primary CEA. When the results
reported herein are pooled with seven other studies of sec-
ondary CEA published from 1995 to 1999,4-6,9,10,12,16
the perioperative stroke rate is 2.6% (14/530), with a 95%
CI of 1.3% to 4.0%, the perioperative mortality rate is
0.75% (4/530), with a 95% CI of 0.1% to 1.4%, and the
combined stroke or death rate is 3.4% (18/530), with a
95% CI of 1.9% to 4.9%. Although these results are not
the gold standard when compared with primary CEA, the
perioperative stroke rates and their 95% CI are below the
upper threshold of approximately 4.5% to 5.0% for series
containing a similar mix of patients with and without
symptoms undergoing primary CEA (6% and 3% thresh-
old, respectively).
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The frequency of cranial nerve palsies after secondary
operations ranges from 3% to 20% in large series.1,2 My
experience with cranial nerve injuries for both primary and
secondary CEA is that they become less frequent over
time. All three of the injuries reported herein occurred
early in this series. Avoidance of densely scarred areas and
careful dissection along the plane of the common and
internal carotid arteries proximal and distal to the prior
CEA should prevent most injuries.
A comparison of the late outcomes of secondary CEAs
with that of the primary CEAs that I performed is inter-
esting. The 5-year and 10-year survival rates for 1360 pri-
mary CEAs between 1983 and 1998 were 89.6% ± 1.5%
and 77.4% ± 4.6%.22 This is significantly higher than the
survival rates after secondary operations in this report
(73.5% ± 6.7% 5-year and 53.5% ± 9.3% 10-year, P = .02).
Although Cox proportional hazard analysis indicates a sig-
nificant dependence of late death on age, the mean age of
the primary CEA was 67 years, and that of the patients
who underwent reoperation was 68 years. Thus, age at the
time of operation is not the reason for the higher mortal-
ity rate after reoperations. The late stroke rates for my pri-
mary and secondary CEAs were almost identical (5-year
92.3% vs 90.3% and 10-year 84.3% vs 86.0%). Similarly the
≥ 50% restenosis-free rates for my primary and secondary
CEAs were similar (5-year 93.8% vs 88.2% and 10-year
64.1% vs 68.1%). Finally, the ≥ 70% restenosis-free rates
for my primary and secondary CEAs were almost identical
(5 years 97.3% vs 97.4%, 10 years 79.6% vs 77.9%). These
data indicate that the major difference in late outcomes
between primary and secondary CEAs is a higher late
mortality rate in the latter.
In this report reoperation was more frequent in arter-
ies in women (55.1% [38/69]). This is consistent with
many studies indicating that women are more likely to
have recurrent stenosis than men after primary CEA.
However, a review of series of secondary carotid artery
operations that supply sex-related data gives a slightly dif-
ferent picture. Pooled data from 10 non–Veterans
Administration Institutions* indicate that only 44.3%
(309/598) of secondary CEAs were in women. This is in
contrast to the 74.2% (23/31) incidence of secondary
recurrent operations (tertiary procedures) in women
reported by Rosenthal et al24 from data pooled from the
Southern Association for Vascular Surgery. Furthermore,
my re-restenosis rate was higher in men than in women.
The reasons for this bimodal sex-related difference
between primary restenosis, secondary operations, sec-
ondary restenosis, and secondary reoperations is unclear.
The finding of recurrent and re-recurrent stenosis in
the distal common carotid artery near the endarterec-
tomy-produced step is not new. When the results of this
study are pooled with three reports that provide location
data,5,12,13 there is a 30.4% (80/263) incidence of the
major restenosis being located in the distal common
carotid artery. I found a trend for late recurrence and re-
recurrence to occur in the distal common carotid artery,
*References 2, 5-7, 10, 11, 14-16, and 18.
whereas early restenosis is more likely in the internal
carotid artery segment. Patch material and closure type
may play little or no role in common carotid artery recur-
rence, whereas both have been implicated in internal
carotid artery recurrent stenosis.
Two major controversial and unanswered questions
concerning secondary carotid artery operations are the
perioperative and late outcome advantages, if any, of one
patch or bypass material over another and of patch recon-
struction versus bypass graft. There are no prospective
randomized trials addressing these issues. In addition to
this retrospective report, which does not indicate any
advantage of one material or method, three publica-
tions2,10,12 give a breakdown of outcomes by materials
and methods. Table III gives the pooled early and late
stroke and ≥ 50% re-restenosis results by three materials
(vein, Dacron, PTFE) and two methods (patch, bypass
graft). A true meta-analysis of these four databases is not
given and is probably invalid, because the studies were not
prospectively randomized nor are they homogeneous with
respect to type of reconstruction (bypass graft or patch) or
material (vein or synthetic). However, an overview of the
pooled outcomes gives some interesting insight into these
questions. For reoperations with patching (n = 206), there
are not enough PTFE (n = 7) data to consider it objec-
tively. Saphenous vein patch and Dacron patch reopera-
tions have similar outcomes. For bypassed operations (n =
115) there are nine Dacron grafts. However, PTFE bypass
grafts have statistically significantly better ≥ 50% re-
restenosis and combined stroke or re-restenosis outcomes
than do saphenous vein and Dacron bypass grafts.
Combining patched and bypassed data, PTFE appears to
be the material of choice because of its excellent perfor-
mance as a bypass graft. Comparison of the results of
patching to bypass graft for each material and for all mate-
rials gives a balanced picture of equal outcomes. Overall,
for patch reconstruction saphenous vein and Dacron have
comparable outcomes and for bypass graft, PTFE may be
superior.
There is controversy over reoperation for asympto-
matic recurrent carotid artery stenosis. O’Donnell et al16
recommend an aggressive operative approach to asympto-
matic ≥ 75% recurrent stenosis. Ricotta and O’Brien-Irr,25
with a less than 5-year follow-up, found that approxi-
mately half of the patients with ≥ 50% recurrent stenosis
required reoperation. They also found an increased inci-
dence of late stroke in patients with recurrent stenosis
compared with those without recurrence. The recent
trend toward reoperation for severe asymptomatic resten-
osis is reflected by 58.5% of Rockman et al10 series and
50% of Hill et al.12 Recently Hobson et al26 demonstrated
that balloon angioplasty with stenting may be an accept-
able alternative to reoperation.
The percentage of all CEAs that are reoperative pro-
cedures varies between series. Stoney and String13 in an
early report had a 1.5% (24/1654) incidence, Mansour et
al6 had a 6.8% (82/1209) rate over 20 years, Ballinger et
al5 had a 7.6% (67/884) rate over 11 years, Hill et al12
had a 10.2% (40/390) rate over 4 years, and O’Donnell et
al16 had an 11.6% (4/346) rate. However, the above rates
include patients with recurrence from the authors’ primary
CEAs and referred patients who had undergone original
CEAs by other surgeons. Gagne et al14 found a 1.6%
(47/2,960) rate of reoperation in their own primary CEA
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Table III. Pooled stroke (perioperative and late) and ≥ 50% re-restenosis outcomes by materials for patched and
bypassed reoperations from this report and three published series2,10,12
Stroke ≥ 50% Re-restenosis Stroke or re-restenosis
Patch*
Vein (n = 64) 2 (3.1%) 11 (17.4%) 13 (20.3%
PTFE (n = 7) 0 (0%) 0 (0%) 0 (0%)
Dacron (n = 135) 8 (5.8%) 28 (20.4%) 36 (26.3%)
Synthetic† (n = 142) 8 (5.6%) 28 (19.7%) 36 (25.4%)
All (n = 206) 10 (4.8%) 39 (18.8%) 49 (23.6%)
Bypass graft‡
Vein (n = 78) 3 (3.8%) 15 (19.2%) 18 (23.1%)
PTFE (n = 28) 1 (3.6%) 0 (0%) 1 (3.6%)
Dacron (n = 9) 2 (22.2%) 1 (11.1%) 3 (33.3%)
Synthetic† (n = 37) 3 (8.1%) 1 (2.7%) 4 (10.8%)
All (n = 115) 6 (5.2%) 16(13.9%) 22(19.1%)
Patch + bypass graft§
Vein (n = 142) 5 (3.5%) 26 (18.3%) 31 (21.8%)
PTFE (n = 35) 1 (2.8%) 0 (0%) 1 (2.8%)
Dacron (n = 179) 10 (6.9%) 29 (20.1%) 39 (27.1%)
Synthetic† (n = 179) 11 (6.1%) 29 (16.2%) 40 (22.3%)
All (n = 321) 16 (5.0%) 55 (17.1%) 71 (22.1%)
*P > .05 for comparison of all combinations of patch materials.
†Synthetic is PTFE plus Dacron.
‡For stroke all P > .05; for re-restenosis P = .019 for vein vs synthetic and P = .010 for vein vs PTFE; for stroke or re-restenosis P = .022 for vein vs PTFE
and P = .038 for Dacron vs PTFE.
§For stroke all P > .05; for re-restenosis P = .003 for vein vs PTFE, P = .002 for Dacron vs PTFE; for stroke or re-restenosis P = .006 for vein vs PTFE, 
P = .001 for Dacron vs PTFE; for all patch vs all bypass grafts P > .05 for stroke and for re-restenosis.
over 22 years. My results are similar: a 1.9% (29/1514)
incidence for patients on whom I performed primary CEA
and a 4.4% (69/1583) rate for all CEAs.
CONCLUSIONS
Carotid artery reoperations are more frequent after
primary CEA with primary closure than after those with
patch angioplasty. Reoperations after initial reconstruction
with vein patches occur later than those primarily closed
and those reconstructed with Dacron patches. Peri-
operative mortality and stroke rates for carotid artery
reoperations are within the acceptable threshold for pri-
mary CEA. Late mortality rates after reoperative carotid
artery procedures are higher than after primary CEA, but
stroke and re-restenosis rates are similar. The perioperative
stroke, late stroke, and re-restenosis rates for vein- and
Dacron-patched reoperations are similar, as are the out-
comes for patch reconstruction and interposition bypass.
Pooled analysis of published data indicates that secondary
patch angioplasty reconstruction and interposition bypass
graft have similar outcomes, that vein- and Dacron-
patched reoperations have similar outcomes, and that
PTFE is superior to vein and Dacron when used as a
bypass graft.
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